RNAZ Financial Statements

Balance sheet, income statement, cash flow, and dividends for Transcode Therapeutics Inc (RNAZ).


$1.76M Market Cap.

As of 04/16/2025 5:00 PM ET (MRY) • Disclaimer

RNAZ Market Cap. (MRY)


RNAZ Shares Outstanding (MRY)


RNAZ Assets (MRY)


Total Assets

$7.29M

Total Liabilities

$9.31M

Total Investments

$0

RNAZ Income (MRY)


Revenue

$0

Net Income

-$16.75M

Operating Expense

$15.66M

RNAZ Cash Flow (MRY)


CF Operations

-$13.34M

CF Investing

-$21.76K

CF Financing

$16.40M

RNAZ Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

RNAZ Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$7,294,499 (41.10%)

$5,169,701 (-31.87%)

$7,587,986 (-66.92%)

$22,938,443 (2073.50%)

Assets Current

$7,093,338 (59.21%)

$4,455,444 (-39.62%)

$7,379,405 (-67.54%)

$22,732,175 (2634.81%)

Assets Non-Current

$201,161 (-71.84%)

$714,257 (242.44%)

$208,581 (1.12%)

$206,268 (-7.98%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$2,018,734 (-223.03%)

$1,640,814 (-49.37%)

$3,240,696 (-84.12%)

$20,404,346 (698.68%)

Property Plant & Equipment Net

$89,305 (-85.18%)

$602,401 (188.81%)

$208,581 (1.12%)

$206,268 (0%)

Cash & Equivalents

$5,811,064 (109.97%)

$2,767,598 (-44.30%)

$4,968,418 (-76.14%)

$20,825,860 (2415.15%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$25,408 (-6.09%)

$27,057 (0%)

$0 (0%)

$30,528 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$360,229 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,708,137 (-11.25%)

$3,051,259 (-29.81%)

$4,347,290 (73.64%)

$2,503,569 (518.38%)

Accumulated Retained Earnings (Deficit)

-$63,201,916 (-36.16%)

-$46,416,344 (-66.54%)

-$27,870,249 (-170.45%)

-$10,305,281 (-197.68%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$38,291 (-91.50%)

$450,571 (0%)

$0 (0%)

$0 (0%)

Debt Current

$38,291 (-90.71%)

$412,280 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$38,291 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$9,313,233 (163.91%)

$3,528,887 (-18.83%)

$4,347,290 (71.55%)

$2,534,097 (-43.23%)

Liabilities Current

$2,771,836 (-20.59%)

$3,490,596 (-19.71%)

$4,347,290 (71.55%)

$2,534,097 (525.92%)

Liabilities Non-Current

$6,541,397 (16983.38%)

$38,291 (0%)

$0 (0%)

$0 (0%)

RNAZ Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$5,954,339 (-16.78%)

$7,154,986 (-15.16%)

$8,433,448 (148.25%)

$3,397,169 (668.34%)

Research & Development Expense

$9,706,358 (-20.85%)

$12,263,530 (19.85%)

$10,232,366 (271.55%)

$2,753,966 (868.14%)

Operating Expenses

$15,660,697 (-19.35%)

$19,418,516 (4.03%)

$18,665,814 (203.45%)

$6,151,135 (746.56%)

Interest Expense

$26,813 (-52.03%)

$55,899 (0%)

$0 (0%)

$95,070 (-75.91%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$16,754,971 (9.66%)

-$18,546,095 (-5.59%)

-$17,564,968 (-156.67%)

-$6,843,399 (-191.97%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$16,754,971 (9.66%)

-$18,546,095 (-5.59%)

-$17,564,968 (-156.67%)

-$6,843,399 (-191.97%)

Preferred Dividends Income Statement Impact

$30,601 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$16,785,572 (9.49%)

-$18,546,095 (-5.59%)

-$17,564,968 (-156.67%)

-$6,843,399 (-191.97%)

Weighted Average Shares

$356,115 (98.94%)

$179,006 (-72.41%)

$648,862 (54.02%)

$421,294 (81.74%)

Weighted Average Shares Diluted

$356,115 (98.94%)

$179,006 (-72.41%)

$648,862 (54.02%)

$421,294 (81.74%)

Earning Before Interest & Taxes (EBIT)

-$16,728,158 (9.53%)

-$18,490,196 (-5.27%)

-$17,564,968 (-160.29%)

-$6,748,329 (-246.19%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$15,660,697 (19.35%)

-$19,418,516 (-4.03%)

-$18,665,814 (-203.45%)

-$6,151,135 (-746.56%)

RNAZ Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$21,761 (38.89%)

-$35,609 (64.72%)

-$100,919 (59.92%)

-$251,820 (0%)

Net Cash Flow from Financing

$16,401,174 (3.09%)

$15,909,324 (265542.41%)

$5,989 (-99.98%)

$25,516,549 (2185.37%)

Net Cash Flow from Operations

-$13,335,947 (26.22%)

-$18,074,535 (-14.67%)

-$15,762,512 (-199.28%)

-$5,266,885 (-968.40%)

Net Cash Flow / Change in Cash & Cash Equivalents

$3,043,466 (238.29%)

-$2,200,820 (86.12%)

-$15,857,442 (-179.30%)

$19,997,844 (3107.12%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$21,761 (38.89%)

-$35,609 (64.72%)

-$100,919 (59.92%)

-$251,820 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$16,401,174 (3.09%)

$15,909,324 (265542.41%)

$5,989 (-99.98%)

$26,377,492 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,699,999 (63.95%)

$1,036,889 (162.29%)

$395,329 (112.55%)

$185,996 (309.29%)

Depreciation Amortization & Accretion

$534,857 (3.50%)

$516,746 (424.05%)

$98,606 (132.18%)

$42,470 (0%)

RNAZ Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-1212.00% (-29.67%)

-934.70% (-444.38%)

-171.70% (-92.49%)

-89.20% (-185.93%)

Return on Average Assets (ROAA)

-287.60% (-4.17%)

-276.10% (-106.66%)

-133.60% (-148.33%)

-53.80% (85.54%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

2147.20% (19.93%)

1790.40% (-20.09%)

2240.40% (475.65%)

-596.40% (-324.48%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

0 (0%)

-0.06 (87.17%)

-0.5 (84.09%)

-3.14

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

-0.87 (-143.24%)

2.02 (-25.08%)

2.69 (67.81%)

1.61

Debt to Equity Ratio (D/E)

-4.61 (-314.46%)

2.15 (60.40%)

1.34 (981.45%)

0.12 (109.47%)

Earnings Per Share (EPS)

-16,785,572 (-16200625.80%)

-103.61 (-283.74%)

-27 (-66.67%)

-16.2 (-58.82%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-37.51 (62.92%)

-101.17 (-313.82%)

-24.45 (-86.64%)

-13.1 (-515.84%)

Book Value Per Share (BVPS)

-5.67 (-161.85%)

9.17 (83.54%)

4.99 (-89.69%)

48.43 (429.41%)

Tangible Assets Book Value Per Share (TABVPS)

20.48 (-29.07%)

28.88 (146.96%)

11.69 (-78.52%)

54.45 (1095.87%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

-2

Enterprise Value Over EBITDA (EV/EBITDA)

-0 (-101.02%)

0.2 (6466.67%)

0 (100.20%)

-1.53

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

2.56 (100.55%)

1.28 (-24.81%)

1.7 (-81.08%)

8.97 (336.97%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$13,357,708 (26.24%)

-$18,110,144 (-14.16%)

-$15,863,431 (-187.45%)

-$5,518,705 (-1019.48%)

Enterprise Value (EV)

$39,809 (101.12%)

-$3,546,156 (-6136.43%)

-$56,862 (-100.55%)

$10,277,762

Earnings Before Tax (EBT)

-$16,754,971 (9.66%)

-$18,546,095 (-5.59%)

-$17,564,968 (-156.67%)

-$6,843,399 (-191.97%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$16,193,301 (9.90%)

-$17,973,450 (-2.90%)

-$17,466,362 (-160.46%)

-$6,705,859 (-244.01%)

Invested Capital

-$1,250,110 (-95.97%)

-$637,922 (63.08%)

-$1,727,722 (-309.88%)

-$421,514 (-122.08%)

Working Capital

$4,321,502 (347.89%)

$964,848 (-68.18%)

$3,032,115 (-84.99%)

$20,198,078 (4637.41%)

Tangible Asset Value

$7,294,499 (41.10%)

$5,169,701 (-31.87%)

$7,587,986 (-66.92%)

$22,938,443 (2073.50%)

Market Capitalization

$1,763,190 (-46.76%)

$3,312,084 (-62.08%)

$8,733,678 (-73.35%)

$32,777,618

Average Equity

$1,385,000 (-30.19%)

$1,984,095 (-80.60%)

$10,228,484 (33.36%)

$7,669,562 (439.51%)

Average Assets

$5,836,415 (-13.11%)

$6,717,400 (-48.93%)

$13,152,258 (3.44%)

$12,714,722 (1918.47%)

Invested Capital Average

-$779,082 (24.56%)

-$1,032,743 (-31.73%)

-$784,008 (-169.29%)

$1,131,497 (-18.42%)

Shares

523,202 (4.13%)

502,440 (-22.57%)

648,862 (0.56%)

645,229 (7.83%)